July/August 2025: Oral Gepotidacin for the Treatment of Uncomplicated Urogenital Gonorrhoea (EAGLE-1): A Phase 3 Randomised, Open-label, Non-inferiority, Multicentre Study

Aug 12, 2025

Article and Study Summary: Article: Oral gepotidacin for the treatment of uncomplicated urogenital gonorrhoea (EAGLE-1): a phase 3 randomised, open-label, non-inferiority, multicentre study Published in: Lancet. 2025;405(10489):1608–1620....

March/April 2025: Oral Regimens for Rifampin-Resistant, Fluoroquinolone-Susceptible Tuberculosis

Apr 28, 2025

Article and Study Summary: Article: Oral Regimens for Rifampin-Resistant, Fluoroquinolone-Susceptible Tuberculosis Published in: N Engl J Med. 2025;392(5):468–482. https://www.nejm.org/doi/full/10.1056/NEJMoa2400327 Authors: Guglielmetti L, Khan U, Velásquez GE, et...

November/December 2024: Twice-Yearly Lenacapavir for HIV Prevention in Men and Gender-Diverse Persons

Dec 19, 2024

Article and Study Summary: Article Twice-Yearly Lenacapavir for HIV Prevention in Men and Gender-Diverse Persons Published in: N Engl J Med. Published online November 27, 2024. https://doi.org/10.1056/NEJMoa2411858 Authors: Kelley CF, Acevedo-Quiñones M, Agwu AL, et...

September/October 2024: Twice-Yearly Lenacapavir or Daily F/TAF for HIV Prevention in Cisgender Women

Oct 28, 2024

Article and Study Summary: Article Twice-Yearly Lenacapavir or Daily F/TAF for HIV Prevention in Cisgender Women Published in: N Engl J Med. 2024;391(13):1179–1192. https://doi.org/10.1056/NEJMoa2407001 Authors: Bekker L, Das M, Abdool Karim Q, et al. for the PURPOSE...

July/August 2024: Implementing an Antimicrobial Stewardship Program in an Oncology Center in Lima, Peru: A Model for Low-and Middle-Income Countries

Sep 5, 2024

Article and Study Summary: Article Implementing an Antimicrobial Stewardship Program in an Oncology Center in Lima, Peru: A Model for Low-and Middle-Income Countries. Published in: Open Forum Infectious Diseases. 2024; 4(8):...

Journal Club